Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cells for decompensated cirrhosis with acute-on-chronic liver failure
RBR-8n8csfPhase 2Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Sep 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow-derived mesenchymal stem cells in Cirrhosis, acute-on-chronic liver failure (ACLF), sponsored by Hospital de Clínicas de Porto Alegre. Started Sep 2018; status: completed.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
Cirrhosisacute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on RBR-8n8csf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8n8csf.